California Public Employees Retirement System
CNCE

California Public Employees Retirement System’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

California Public Employees Retirement System’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-58,500
Closed -$292K – 3233
2021
Q1 		$292K Sell
58,500
-5,473
-9% -$44.2K ﹤0.01% 3235
2020
Q4 		$809K Sell
63,973
-1,200
-2% -$13.7K ﹤0.01% 2626
2020
Q3 		$640K Buy
65,173
+1,800
+3% +$17.7K ﹤0.01% 2595
2020
Q2 		$631K Sell
63,373
-12,316
-16% -$118K ﹤0.01% 2538
2020
Q1 		$669K Sell
75,689
-42,411
-36% -$418K ﹤0.01% 2238
2019
Q4 		$1.09M Sell
118,100
-36,400
-24% -$258K ﹤0.01% 2319
2019
Q3 		$908K Buy
154,500
+8,500
+6% +$90.2K ﹤0.01% 2319
2019
Q2 		$1.75M Sell
146,000
-3,079
-2% -$33.1K ﹤0.01% 1789
2019
Q1 		$1.8M Buy
149,079
+59,800
+67% +$881K ﹤0.01% 1845
2018
Q4 		$1.12M Buy
89,279
+4,800
+6% +$66.3K ﹤0.01% 2118
2018
Q3 		$1.25M Sell
84,479
-3,600
-4% -$56.6K ﹤0.01% 2197
2018
Q2 		$1.48M Buy
88,079
+3,079
+4% +$59.8K ﹤0.01% 2097
2018
Q1 		$1.95M Hold
85,000
– – ﹤0.01% 1898
2017
Q4 		$2.2M Hold
85,000
– – ﹤0.01% 1887
2017
Q3 		$1.25M Hold
85,000
– – ﹤0.01% 2164
2017
Q2 		$1.19M Hold
85,000
– – ﹤0.01% 2170
2017
Q1 		$1.45M Hold
85,000
– – ﹤0.01% 2073
2016
Q4 		$875K Hold
85,000
– – ﹤0.01% 2402
2016
Q3 		$859K Hold
85,000
– – ﹤0.01% 2435
2016
Q2 		$955K Hold
85,000
– – ﹤0.01% 2367
2016
Q1 		$1.16M Sell
85,000
-18,700
-18% -$269K ﹤0.01% 2234
2015
Q4 		$1.97M Buy
103,700
+18,700
+22% +$406K ﹤0.01% 1942
2015
Q3 		$1.59M Hold
85,000
– – ﹤0.01% 2064
2015
Q2 		$1.27M Hold
85,000
– – ﹤0.01% 2355
2015
Q1 		$1.18M Hold
85,000
– – ﹤0.01% 2474
2014
Q4 		$1.18M Hold
85,000
– – ﹤0.01% 2474
2014
Q3 		$1.07M Hold
85,000
– – ﹤0.01% 2468
2014
Q2 		$859K Hold
85,000
– – ﹤0.01% 2656
2014
Q1 		$1.02M Buy
+85,000
New +$1.2M ﹤0.01% 2515

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

California Public Employees Retirement System's CNCE Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 58,500 shares — an estimated $292K sold.

California Public Employees Retirement System first reported a position in CNCE in Q1 2014 and held it in 29 quarters. The position peaked at $2.2M in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 58,500 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $292K.
  • California Public Employees Retirement System first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 29 quarters.
  • California Public Employees Retirement System's Concert Pharmaceuticals, Inc. position peaked at $2.2M in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.